Cerner Collaboration to Increase Access to Cancer Clinical Trials

The company's Learning Health Network teams with Elligo Health Research and Freenome to Advance Early Cancer Detection

KANSAS CITY, Mo., May 18, 2022 /PRNewswire/ -- Cerner Corporation (NASDAQ: CERN), Elligo Health Research^® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection. Together they will be using the research-activated network of health systems, real-world data (RWD) and multiomics technology, developed by Freenome, with the goal to help accelerate early cancer detection.